Literature DB >> 15353581

Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.

Svetlana Mukhina1, Hichem C Mertani, Ke Guo, Kok-Onn Lee, Peter D Gluckman, Peter E Lobie.   

Abstract

We report here that autocrine production of human growth hormone (hGH) results in a phenotypic conversion of mammary carcinoma cells such that they exhibit the morphological and molecular characteristics of a mesenchymal cell, including expression of fibronectin and vimentin. Autocrine production of hGH resulted in reduced plakoglobin expression and relocalization of E-cadherin to the cytoplasm, leading to dissolution of cell-cell contacts and decreased cell height. These phenotypic changes were accompanied by an increase in cell motility, elevated activity of specific matrix metalloproteinases, and an acquired ability to invade a reconstituted basement membrane. Forced expression of plakoglobin significantly decreased mammary carcinoma cell migration and invasion stimulated by autocrine hGH. In vivo, autocrine hGH stimulated local invasion of mammary carcinoma cells concomitant with a prominent stromal reaction in comparison with well delineated and capsulated growth of mammary carcinoma cells lacking autocrine production of hGH. Thus, autocrine production of hGH by mammary carcinoma cells is sufficient for generation of an invasive phenotype. Therapeutic targeting of autocrine hGH may provide a mechanistic approach to prevent metastatic extension of human mammary carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353581      PMCID: PMC524067          DOI: 10.1073/pnas.0405881101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland.

Authors:  M Raccurt; P E Lobie; E Moudilou; T Garcia-Caballero; L Frappart; G Morel; H C Mertani
Journal:  J Endocrinol       Date:  2002-11       Impact factor: 4.286

2.  Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer.

Authors:  K Pantel; B Passlick; J Vogt; P Stosiek; M Angstwurm; R Seen-Hibler; K Häussinger; O Thetter; J R Izbicki; G Riethmüller
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Expression of the gene encoding growth hormone in the human mammary gland.

Authors:  J A Mol; S C Henzen-Logmans; P Hageman; W Misdorp; M A Blankenstein; A Rijnberk
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

4.  Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis.

Authors:  Mikhail Menshikov; Eugenia Elizarova; Karina Plakida; Angelika Timofeeva; Georgy Khaspekov; Robert Beabealashvilli; Alex Bobik; Vsevolod Tkachuk
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

5.  Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.

Authors:  C L Sommers; E P Gelmann; R Kemler; P Cowin; S W Byers
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

6.  Differentiation state and invasiveness of human breast cancer cell lines.

Authors:  C L Sommers; S W Byers; E W Thompson; J A Torri; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Cross-talk between adherens junctions and desmosomes depends on plakoglobin.

Authors:  J E Lewis; J K Wahl; K M Sass; P J Jensen; K R Johnson; M J Wheelock
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

8.  Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.

Authors:  I Simcha; B Geiger; S Yehuda-Levenberg; D Salomon; A Ben-Ze'ev
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

9.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion.

Authors:  J Behrens; M M Mareel; F M Van Roy; W Birchmeier
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

10.  The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin).

Authors:  M G Lampugnani; M Corada; L Caveda; F Breviario; O Ayalon; B Geiger; E Dejana
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  54 in total

1.  The oncogenic potential of autocrine human growth hormone in breast cancer.

Authors:  Michael J Waters; Becky L Conway-Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-12       Impact factor: 11.205

2.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Authors:  Weijie Zhang; Pengxu Qian; Xiao Zhang; Min Zhang; Hong Wang; Mingming Wu; Xiangjun Kong; Sheng Tan; Keshuo Ding; Jo K Perry; Zhengsheng Wu; Yuan Cao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

Review 3.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

5.  Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.

Authors:  M Victoria Recouvreux; J Boyang Wu; Allen C Gao; Svetlana Zonis; Vera Chesnokova; Neil Bhowmick; Leland W Chung; Shlomo Melmed
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

6.  Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval.

Authors:  M D Slater; C R Murphy
Journal:  J Mol Histol       Date:  2006-06-29       Impact factor: 2.611

Review 7.  Growth hormone in the tumor microenvironment.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Arch Endocrinol Metab       Date:  2019 Nov-Dec       Impact factor: 2.309

8.  Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells.

Authors:  Ajda Coker-Gurkan; Derya Bulut; Recep Genc; Elif-Damla Arisan; Pınar Obakan-Yerlikaya; Narcin Palavan-Unsal
Journal:  Mol Biol Rep       Date:  2018-11-23       Impact factor: 2.316

9.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 10.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.